The production built a massive financial foundation by generating Rs 334.35 crore in its initial week before tacking on an additional Rs 89.67 crore over the second week. By its fifteenth day of release, daily business softened to Rs 1.49 crore net across 3,878 tracked shows nationwide. Tamil and Telugu circuits provided the majority of those Day 15 receipts, while the Hindi market added Rs 0.21 crore from 1,322 screenings.
Key points
Second-week receipts added Rs 89.67 crore to the box office tally after a Rs 334.35 crore…: Second-week receipts added Rs 89.67 crore to the box office tally after a Rs 334.35 crore debut week.
Regional language markets including Telugu and Hindi are contributing supplementary reven…: Regional language markets including Telugu and Hindi are contributing supplementary revenues across thousands of nationwide screenings.
Upcoming ticket receipts during the extended theatrical run will determine whether the fe…: Upcoming ticket receipts during the extended theatrical run will determine whether the feature reaches a Rs 1,000 crore worldwide milestone.
Sources checked by our analysis pipeline: 1
Rajinikanth’s 'Jailer 2' is doing well at the box office and is almost reaching Rs 500 crore in the domestic market. This film, directed by Nelson Dilipkumar, has stayed in most theaters even after the two-week release. The action sequel has benefited from its multi-language release and the star power of its leading cast. Although daily collections have slowed during the third week, the film has added to its impressive total.
Jailer 2 Movie Review‘Jailer 2’ India box office collection crosses Rs 424 crore net
According to Sacnilk, 'Jailer 2' opened with Rs 59.70 crore on its first day and continued its strong run during the opening week. The film collected Rs 334.35 crore during its opening week, followed by Rs 89.67 crore in its second week. Its strong first-week performance gave the Rajinikanth-starrer a solid start, while the second-week earnings added to its overall box office total. However, daily collections have slowed as the film enters its third week.
‘Jailer 2’ Day 15 Live box office collection
On Day 15, 'Jailer 2' is running across 3,878 tracked shows and…
Strong domestic performance at the flagship burger chain helped bolster corporate profits despite persistent revenue pressures elsewhere in the portfolio. Fast-food competitors leveraging aggressive promotional discounts have continued to lure diners away from the company's chicken division. Consequently, executives are refining operational efficiency and core menu offerings to stabilize struggling banners.
Robust commercial adoption of novel cancer therapies and vaccines is reinforcing the drugmaker's financial cushion against looming exclusivity losses. Growth across core pharmaceutical lines offset softer performance within the veterinary business, providing sufficient momentum to absorb significant transaction costs. This operational resilience positions the enterprise to aggressively defend its primary oncology franchise ahead of key patent expirations.
Robust quarterly execution has bolstered the energy group's near-term operational standing across its core markets. However, mounting capital expenditures at the key Dutch facility threaten to weigh on long-term project returns and cash allocation. Stakeholders now face a delicate balance between immediate profitability and the expanding financial commitments required to complete major infrastructure developments.